Monoclonal antibodies against calcitonin gene-related peptide for migraine prophylaxis: a systematic review of real-world data
AR Pavelic, C Wöber, F Riederer, K Zebenholzer - Cells, 2022 - mdpi.com
Objective: To perform a systematic review of real-world outcomes for anti-CGRP-mAbs.
Methods: Following the PRISMA guidelines, we searched PubMed for real-world data of …
Methods: Following the PRISMA guidelines, we searched PubMed for real-world data of …
Red flags in primary mitochondrial diseases: what should we recognize?
Primary mitochondrial diseases (PMDs) are complex group of metabolic disorders caused
by genetically determined impairment of the mitochondrial oxidative phosphorylation …
by genetically determined impairment of the mitochondrial oxidative phosphorylation …
Effectiveness and safety of CGRP monoclonal antibodies in migraine related to mitochondrial diseases in patients with NARP and PEO syndromes
M Silvestro, I Orologio, F Trojsi, A Tessitore… - Clinical Neurology and …, 2023 - Elsevier
3. Discussion We described the cases of two female patients with different genetically
determined mitochondrial diseases (ie NARP and PEO) and chronic migraine exhibiting …
determined mitochondrial diseases (ie NARP and PEO) and chronic migraine exhibiting …
Migräne und mitochondriale Erkrankungen
L Hämmerl, T Kraya - Der Nervenarzt, 2024 - Springer
Mitochondriale Erkrankungen (ME) sind vielschichtige Stoffwechselerkrankungen, die durch
Genmutationen hervorgerufen werden und zu einer gestörten Energiegewinnung in den …
Genmutationen hervorgerufen werden und zu einer gestörten Energiegewinnung in den …